Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma.
Saved in:
| Title: | Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma. |
|---|---|
| Authors: | Yopp A; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: adam.yopp@UTSouthwestern.edu., Chen M; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangdong Province, China., Cheng AL; Department of Medical Oncology, National Taiwan University Cancer Center and Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Kaseb A; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan., Lee HC; Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Cha E; Product Development Oncology, Genentech Inc, South San Francisco, CA, USA., Hack SP; Product Development Oncology, Genentech Inc, South San Francisco, CA, USA., Lian Q; Biostatistics, Genentech Inc, South San Francisco, CA, USA., Spahn J; Product Development Oncology, Genentech Inc, South San Francisco, CA, USA., Wu C; Portfolio Clinical Safety, Roche (China) Holding Ltd, Shanghai, China., Qin S; Department of Medical Oncology, Jinling Hospital of Nanjing University of Chinese Medicine, Nanjing, China., Chow PK; Division of HPB and Transplant Surgery, National Cancer Centre Singapore and Singapore General Hospital, Singapore and Surgery Academic Clinical Programme, Duke-NUS Medical School Singapore, Singapore. |
| Source: | Journal of hepatology [J Hepatol] 2026 Jun; Vol. 84 (6), pp. 1102-1111. Date of Electronic Publication: 2026 Jan 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
